$10.70
1.71% (Daily)
Market Cap
$154.31M
Revenue
$112.81M
Rank by MCap
#1797
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Cheryl Renee Blanchard Ph.D.
Headquarters
Bedford, MA
Employees
288
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectab...
Loading chart…